Clinical Trial Update: Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating intrathecal DepoCyte (liposomal cytarabine) with lineage-targeted minimal residual disease-oriented therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Depocyte

Snippet

Sponsor: Northern Italy Leukemia Group | Conditions: Acute Lymphoblastic Leukemia | Phase 2, Phase 3 | Status: COMPLETED